Ultromics

Ultromics will be attending Echocardiography in the Nation’s Capital in Washington, D.C.! If you’re participating in this course, we’d welcome the opportunity to connect. Meet with our team to learn more about EchoGo® and how Ultromics is applying AI in echocardiography to improve precision, efficiency, and early detection in cardiac care. Request a meeting with us: https://lnkd.in/gH2xQd8y

Patricia Pellikka, MD, from Mayo Clinic, discusses the training, validation, and testing behind EchoGo® Heart Failure for HFpEF detection. EchoGo® Heart Failure uses AI to analyze echocardiogram videos to detect HFpEF — supporting the diagnosis of this complex disease. Performance has been rigorously tested, with results published in JACC: Advances, JASE, and Nature Communications. Watch the video to learn more: https://lnkd.in/eKYnwviv #Ultromics #EchoGo #Cardiology #HFpEF #HeartFailure

Today is #WorldHeartDay ❤️ At Ultromics, we’re working to close a major diagnostic gap in cardiovascular care, using AI to help identify patients at risk of complex cardiac diseases, and supporting clinicians in detecting and treating disease earlier. Patricia A. Pellikka, MD (Mayo Clinic), Jeremy A. Slivnick, MD (University of Chicago Medicine), and Faizi A. Jamal, MD, FACC (City of Hope) share their experiences using Ultromics' platform, EchoGo®, in clinical practice to detect HFpEF and cardiac amyloidosis. ▶️ Watch their discussion here: https://lnkd.in/e6HVA-kM #WorldHeartDay2025 #Cardiology #MedTech #Healthcare #HeartFailure #Amyloidosis #HFpEF #Ultromics #EchoGo

Ultromics will be at #HFSA2025! If you're attending the conference, drop us a message to connect with our team and learn more about EchoGo® and how Ultromics is using AI to advance earlier detection and intervention for complex cardiac diseases — starting with HFpEF and cardiac amyloidosis. Request a meeting with us: https://lnkd.in/eANqEJ_q #HFSA #Ultromics #EchoGo #HFpEF #Amyloidosis #Cardiology #DigtialHealth #Echocardiography #EchoFirst

EchoGo® Amyloidosis could improve early detection of cardiac amyloidosis. New study presented at #ASE2025 shows EchoGo® improved detection & reduced unnecessary testing. Read the official press release: https://lnkd.in/eQVCjJEf #Amyloidosis #Cardiology #AIinHealthcare #Echocardiography #Ultromics #EchoGo

Ultromics has been named a WIRED 2025 Trailblazer! 🚀 The WIRED Trailblazer programme celebrates businesses redefining industry standards through innovation, growth, and positive change. Thank you to WIRED Consulting and HSBC Commercial Banking for this recognition, and congratulations to all those selected this year! Over the past few years, Ultromics has grown from an Oxford-founded spinout into a company working with some of the world’s leading hospitals. Our goal has always been simple: close one of healthcare’s biggest diagnostic gaps, heart failure, by using AI to detect disease earlier from routine heart scans. Our next chapter is about continuing to expand our flagship platform, EchoGo®, into the U.S. — already FDA-cleared and Medicare-reimbursed — to bring earlier detection and intervention at scale. Read the full announcement here: https://hubs.la/Q03H_3670 #TrailBlazers

Ultromics has been recognized as part of Tech Nation Future Fifty 2025! It’s an incredible milestone, highlighting our impact in shaping the future of healthcare innovation. We are proud to stand alongside an amazing roster of the best in UK innovation! Ultromics is working to close the diagnostic gap in heart disease and support earlier detection. From developing EchoGo® and advancing the first FDA-cleared and Medicare-reimbursed AI technology for complex cardiac disease detection, to scaling our reach with leading institutions like Mayo Clinic, Northwestern Medicine, and University Hospitals Cleveland, we’re entering the next phase of growth with purpose and momentum. "This recognition reflects the incredible progress our team has made and the growing impact of AI in transforming healthcare. We’re entering the next phase of growth, scaling our technology to reach more clinicians and patients, and helping redefine how heart disease is detected and treated." Ross Upton, PhD Meet the Future Fifty companies of 2025: https://hubs.la/Q03HXyH60 Read our official news announcement: https://hubs.la/Q03HXsQ10 #HealthcareInnovation #DigitalHealth #AIinHealthcare #HeartFailure #Ultromics #EchoGo

📸 Highlights from our Science & Technology Theater session just now at #ASE2025 “Real-world AI for HFpEF and Amyloidosis: Unlocking diagnostic power from a single echo view.” Thank you to everyone who joined us in the room and to American Society of Echocardiography for the opportunity to showcase how our AI tools are advancing heart failure detection. In the photos: 🫀 Faizi A. Jamal, MD (City of Hope) Sharing real-world implementation of EchoGo® Amyloidosis, and how they use reports from EchoGo® to identify and refer suspected Cardiac Amyloidosis cases into referral pathways 🫀 Patricia A. Pellikka, MD (Mayo Clinic) Showcasing progress in detection of HFpEF and amyloid cardiomyopathy with EchoGo®, comparison against clinical scores, and implementation into workflows 🫀 Jeremy A. Slivnick, MD (University of Chicago) Presenting the landmark European Heart Journal study for EchoGo® Amyloidosis and real-world testing across 18+ sites 🫀 Ross Upton, PhD (Ultromics) Introducing EchoGo® and its role in advancing heart failure detection and supporting clinical decisions.

Just presented at #ASE2025: New data from Northwestern using EchoGo® Heart Failure in the clinic. The study showed that patients identified as positive were at a significantly higher risk of hospitalization within 1 year after screening, underscoring the value of AI in supporting earlier intervention for HFpEF. Lead author: Amogh Karnik, MD, MSc, MSAI #HeartFailure #EchoFirst #HFpEF #EchoGo #Ultromics

Grateful to our commercial crew here at #ASE2025 representing Ultromics, and to everyone who’s stopped by to connect with us so far. It’s inspiring to see so much energy around advancing echocardiography and the role of AI in improving diagnosis and treatment 🚀 Roger R. Owens, Nancy Spagou, Hannah James, Garrett Knappe, MBA, Kristy Sweeney-Kee, BS, RDCS, FASE, Jessica Kenney, Kimberly Kenyon